Event Details
62nd European Renal Association (ERA) Congress
Jun 6, 2025
Title: ARO-C3, an investigational RNAi Therapeutic Targeting Complement C3, Reduces Proteinuria, Hematuria, and Complement Activity in IgAN Patients
Supporting Materials
ARO-C3 1.2 MB